Innovative cell therapies for a healthier world
Heart failure affects 26 million people worldwide
The costs associated with Heart Failure exceed 100 billion dollars a year
Did you know?
Rett syndrome is a genetic disease that has no definitive treatment
Rett Syndrome is a disease of the autistic spectrum
What we do
LizarBio Therapeutics is a startup that develops cell therapies based on pluripotent stem cells. We are currently focused on developing therapies for patients with heart and neurological problems. More specifically, congestive heart failure (CHF) and Rett syndrome. We believe that cell therapy is the future of regenerative medicine.
Currently, LizarBio Therapeutics is focused on solving problems in two specific diseases, namely: Heart Failure through the use of cardiac cells and Rett Syndrome with the use of healthy astrocytes, both of the cells produced in the laboratory. In the future, we plan to expand our operations to other areas such as ophthalmology, endocrinology and etc., always producing authentic human cells on a scale.
Ind enablign tests
LizarBio Therapeutics Team
Principal Investigator (Pre-Clinical Tests)
Cell Culture Coordinator
Contact us through the channels below, or fill out the form:
Call us+55 11 3039-8359
Want to work with email@example.com
Antonio is a biologist from Paulista University with a master and doctor degree in human genetics from the Bioscience Institute, University of São Paulo. He has experience in histology and molecular biology, having worked with muscle regeneration in animal models